Literature DB >> 23561916

Effects of combined application of muscle relaxants and celecoxib administration after total knee arthroplasty (TKA) on early recovery: a randomized, double-blind, controlled study.

Long Gong1, Ji-Yuan Dong, Zhi-Rui Li.   

Abstract

The purpose of this study was to evaluate the effectiveness of application of muscle relaxants and celecoxib in early recovery after total knee arthroplasty (TKA). One hundred and fifty patients were randomized 1:1:1 to receive either both of muscle relaxants and celecoxib or muscle relaxants alone or placebo for 2 weeks (50 patients in each group). VAS pain scores as primary efficacy, active range of motion, morphine consumption, blood loss, and postoperative complications including postoperative nausea and vomiting (PONV), extremities myasthenia and deep vein thrombosis (DVT) were determined postoperatively. Group A improved better with reduced VAS pain scores compared with another two groups. These results demonstrated that application of muscle relaxants and celecoxib into patients undergoing TKA for 2 weeks postoperative consequently improved their convalescence.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Keywords:  celecoxib; muscle relaxant; postoperative pain; rehabilitation; total knee arthroplasty (TKA)

Mesh:

Substances:

Year:  2013        PMID: 23561916     DOI: 10.1016/j.arth.2012.10.002

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

1.  [Unexpected hemorrhage complications in association with celecoxib. Spontaneously reported case series after perioperative pain treatment in gynecological operations].

Authors:  T Stammschulte; K Brune; A Brack; H Augenstein; G Arends; U Gundert-Remy
Journal:  Anaesthesist       Date:  2014-12       Impact factor: 1.041

Review 2.  Consensus Guidelines on Interventional Therapies for Knee Pain (STEP Guidelines) from the American Society of Pain and Neuroscience.

Authors:  Corey W Hunter; Timothy R Deer; Mark R Jones; George C Chang Chien; Ryan S D'Souza; Timothy Davis; Erica R Eldon; Michael F Esposito; Johnathan H Goree; Lissa Hewan-Lowe; Jillian A Maloney; Anthony J Mazzola; John S Michels; Annie Layno-Moses; Shachi Patel; Jeanmarie Tari; Jacqueline S Weisbein; Krista A Goulding; Anikar Chhabra; Jeffrey Hassebrock; Chris Wie; Douglas Beall; Dawood Sayed; Natalie Strand
Journal:  J Pain Res       Date:  2022-09-08       Impact factor: 2.832

3.  Inpatient and outpatient opioid requirements after total joint replacement are strongly influenced by patient and surgical factors.

Authors:  Austin J Roebke; Garrhett G Via; Joshua S Everhart; Maria A Munsch; Kanu S Goyal; Andrew H Glassman; Mengnai Li
Journal:  Bone Jt Open       Date:  2020-11-02

Review 4.  The efficacy and safety of selective COX-2 inhibitors for postoperative pain management in patients after total knee/hip arthroplasty: a meta-analysis.

Authors:  Mingyang Jiang; Huachu Deng; Xuxu Chen; Yunni Lin; Xiaoyong Xie; Zhandong Bo
Journal:  J Orthop Surg Res       Date:  2020-02-05       Impact factor: 2.359

5.  The Efficacy and Safety of Celecoxib for Pain Management After Total Knee Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Xiaoyuan Geng; Shangyou Zhou; Xiaoyan Zhang; Xi Liu; Xu Cheng; Lihua Jiang; Donghang Zhang
Journal:  Front Surg       Date:  2022-01-28

6.  Four Methods for Calculating Blood-loss after Total Knee Arthroplasty.

Authors:  Fu-Qiang Gao; Zi-Jian Li; Ke Zhang; Wei Sun; Hong Zhang
Journal:  Chin Med J (Engl)       Date:  2015-11-05       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.